Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 3 Vasculitis 2 Uveitis 2 Granulomatosis with Polyangiitis 2 Arthritis, Juvenile 2 Temporomandibular Joint Disorders 1 Stomatitis 1 Pneumonia 1 Neoplasms 1 Metabolic Syndrome 1 Lupus Nephritis 1 Asthma 1 Arthritis, Rheumatoid 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Lupus Nephritis × Etanercept × Clear all

NCT00447265 2013-02-12

Etanercept for the Treatment of Lupus Nephritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Terminated

1 enrolled 15 charts

Lupus Nephritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡